Abnormal expression of NLK is closely associated with the occurrence and progression of tumors, with high expression in laryngeal cancer, lung cancer, and cervical squamous cell carcinoma [20–22], but with low expression in non-small cell lung cancer, breast cancer, and ovarian cancer [23–25]. The gene discussed is NLK; the disease is non-small cell lung carcinoma.